Stocks · News reference
Arbutus Biopharma Announces Plans For Up To $230M Modified Dutch Auction Tender Offer At $5.00 To $5.75/Share; Expects To Commence August 24, Expire September 29
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 21, 2026, 11:31 AM
- Checked
- Aug 21, 2026, 11:31 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why Is Arbutus Biopharma Stock Gaining Friday?
Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auction. Get the offer details.
Read original at benzingaArbutus Biopharma shares are trading higher after the company announced plans to commence a modified Dutch Auction tender offer to repurchase up to $230 million shares at no less than $5.00 per share and not more than $5.75 per share.
Read original at benzingaArbutus Biopharma Plans To Commence Modified Dutch Auction Tender Offer To Repurchase Up To $230M Of Common Shares At Purchase Price Of Between $5.00 And $5.75 Per Share In Cash
Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified "Dutch
Read original at benzinga